A Tiny Dose — A Massive Alzheimer’s Protection
Physionic
Oct 18, 2025
Episode description
JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 HEALTH AUTONOMY [COURSE]Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomyJOIN THE COMMUNITYJoin my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2EMAIL LIST1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6HIRE ME FOR CONSULTING: Consulting: https://bit.ly/3dmUl2H Created with BiorenderFollow-up Lithium video: https://youtu.be/zC3qBR420A80:00 - Introduction0:23 - Lithium, GSK3, and the Mechanisms of Alzheimer's5:17 - Main PointsReferences[Study 508] Aron L, Ngian ZK, Qiu C, Choi J, Liang M, Drake DM, Hamplova SE, Lacey EK, Roche P, Yuan M, Hazaveh SS, Lee EA, Bennett DA, Yankner BA. Lithium deficiency and the onset of Alzheimer’s disease. Nature. 2025;628(8019):1-14. doi:10.1038/s41586-025-09335-x.Funding/Conflicts: Mixed [Public: NIH / Non-Profit: The JPB Foundation, The Belfer Family Foundation, and The Cure Alzheimer’s Fund] // Potential Conflicts of Interest: B.A.Y. (Bruce A. Yankner) and L.A. (Liviu Aron) are inventors on a pending patent application related to lithium orotate and its therapeutic potential in Alzheimer’s disease. The other authors declared no competing interests[A] Voytovych H, Kriváneková L, Ziemann U. Lithium: a switch from LTD- to LTP-like plasticity in human cortex. Neuropharmacology. 2012;63(2):274-279. doi:10.1016/j.neuropharm.2012.03.023[B] Gould TD, Chen G, Manji HK. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology. 2004;29(1):32-38. doi:10.1038/sj.npp.1300283[C] Snitow ME, Bhansali RS, Klein PS. Lithium and Therapeutic Targeting of GSK-3. Cells. 2021;10(2):255. Published 2021 Jan 28. doi:10.3390/cells10020255CRITIQUES, RULES, AND NOTESBe aware of the following rules before posting comments:- Please do not post summaries of the video in the comments - it damages retention on the video and YouTube is less likely to promote it (these videos cost me a lot of money to produce). Critiques of my work are welcome! Please be aware of the following notes & rules before submitting critique:Be mindful that this content is not all encompassing on the subject at hand and is self-limited for brevity to reach a wider audience. Also, be aware that I receive hundreds of YouTube comments per day, so the only way your critique can be considered is if you follow the steps outlined below. Finally, YouTube auto-deletes links, so I do not see most comments with links attached. RULES:If your comment is rude, you will be banned.If your comment is not about the studies/topics at hand (i.e. extending to other outcomes not discussed) or offers critique with no scientific basis, it is unlikely to receive a response.If you can follow these rules, I will try to address your critique and if there is merit, I will add an AMENDMENT to the content in question and pin it so everyone can see it (thank you!). Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.
Mindsip insights from this episode:
Break negative feedback loop of amyloid plaques in Alzheimer's
The amyloid plaques produced in Alzheimer's can themselves further stimulate the problematic GSK3 enzyme, creating a negative feedback loop.
Utilize lithium to inhibit Alzheimer's disease mechanism
Elemental lithium can directly bind to and inhibit the GSK3 enzyme, counteracting a primary mechanism that promotes Alzheimer's disease.
Understand GSK3's role in tau protein tangles and neuron stability
When GSK3 hyper-tags tau proteins, they stop stabilizing the neuron's transport highways (microtubules) and instead scrunch up to form tangles.
Target GSK3 to inhibit amyloid plaque formation
GSK3 promotes amyloid plaque formation not by acting on the cutting enzymes directly, but by tagging precursor proteins, making them more attractive to be cut.
Investigate lithium and magnesium interaction for brain health
There is an interesting interaction between lithium and magnesium that may influence its effects on the GSK3 enzyme and overall brain health.
Target GSK3 enzyme to combat Alzheimer's pathology
An enzyme called GSK3 is a key driver of Alzheimer's pathology by destabilizing brain cells and encouraging the buildup of protein tangles.
